Abstract

Background: Commonest cause of pleural effusion in India is tuberculosis (TB) and poses a diagnostic difficulty because of the low sensitivity of culture technique. Methods: Prospective study conducted during Jan 2012 to Sept. 2013 with an objective to find role of Nucleic acid amplification tests (NAATs) in tuberculous pleural effusion. We also observed comparison of NAATs i.e. MTB DNA PCR with other conventional diagnostic techniques like pleural fluid biochemistry, ADA (adenosine deaminase level), cytology and culture for mycobacterium tuberculosis, included 100 cases with signs, symptoms, history and radiological features suggestive of tuberculous pleural effusion. All the cases were subjected to pleural fluid analysis, smear for AFB, ADA, cytology, AFB culture on LJ media & MTB DNA PCR. Statistical analysis was done by using t-test and chi-test. Results: Out of total 100 cases with pleural effusion, 09% cases were sputum positive for AFB, 3% pleural fluid samples positive for AFB, 28% were culture positive, 74% were DNA PCR positive, and 85% cases had ADA >40 units/liter, 87% cases had a LN Ratio greater than 0.75. Sensitivity, specificity, PPV & NPV of PCR for MTB was observed 92.86%, 33.33%, 35.13% & 92.30% respectively (p 0.4). In PCR negative cases; there was statistically significant association between ADA levels in pleural fluid culture for MTB positive and negative results. (P 40 units/liter, DNA PCR and LN ratio >0.75 gave a positive diagnostic yield in 98% of cases, 2% with diagnostic dilemma were diagnosed by pleural biopsy. ATT response was observed in 78% cases in 2 weeks, 98% cases in 4 weeks and 100% cases at the end of 6 weeks. Conclusion: In cases with exudative pleural effusion with Lymphocyte in pleural fluid >50% and L/N ratio>0.75 with ADA <40 units, MTB DNA PCR (NAATs) will be very useful in confirming tuberculosis as a cause for pleural effusion. Results of NAATs in this situation are very useful, sensitive, less time consuming and comparable to pleural fluid culture. Hence we recommend MTB DNA PCR in these cases.

Highlights

  • India is the highest tuberculosis burden country with World health Organization (WHO) statistics for 2010 giving an estimated incidence figure of 2.3 million cases of tuberculosis for India out of a global incidence of 9.4 million cases [1]

  • In present study we evaluated role of pleural fluid DNA PCR in tuberculous pleural effusion in high burden settings where case load is remarkable and compared its usefulness with parameters like pleural fluid biochemistry, microbiology, ADA and pleural fluid culture

  • In PCR positive cases of tuberculous pleural, there was no significant association between ADA levels in pleural fluid culture for MTB positive and negative (P>0.4) (Table 2)

Read more

Summary

Introduction

India is the highest tuberculosis burden country with World health Organization (WHO) statistics for 2010 giving an estimated incidence figure of 2.3 million cases of tuberculosis for India out of a global incidence of 9.4 million cases [1]. WHO statistics show that India is 17th out of the 22 high burden countries in terms of tuberculosis incidence rate. Pulmonary tuberculosis is most common presentation; extrapulmonary tuberculosis is an important clinical problem [3,4]. Pleural effusion is one of the common complications of primary tuberculosis or in conjunction with pulmonary infiltrate typical of post primary tuberculosis. Commonest cause of pleural effusion in India is tuberculosis (TB) and poses a diagnostic difficulty because of the low sensitivity of culture technique

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.